(Q43880002)

English

A meta-analysis of the dose-response relationship of inhaled corticosteroids in adolescents and adults with mild to moderate persistent asthma

scientific article published in January 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

27 November 2017

A meta-analysis of the dose-response relationship of inhaled corticosteroids in adolescents and adults with mild to moderate persistent asthma (English)

1 reference

Europe PubMed Central

27 November 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1

object named as

Jean Bousquet

1 reference

Europe PubMed Central

27 November 2017

author name string

Rami Ben-Joseph

2

1 reference

Europe PubMed Central

27 November 2017

Mark Messonnier

3

1 reference

Europe PubMed Central

27 November 2017

Evo Alemao

4

1 reference

Europe PubMed Central

27 November 2017

A Lawrence Gould

5

1 reference

Europe PubMed Central

27 November 2017

publication date

1 January 2002

1 reference

Europe PubMed Central

27 November 2017

Clinical Therapeutics

1 reference

Europe PubMed Central

27 November 2017

24

1 reference

Europe PubMed Central

27 November 2017

1

1 reference

Europe PubMed Central

27 November 2017

1-20

1 reference

Europe PubMed Central

27 November 2017

Inhaled corticosteroids: benefits and risks

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985002-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Issues in the use of inhaled glucocorticoids. The Asthma Clinical Research Network

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985002-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Mometasone furoate antagonizes AMP-induced bronchoconstriction in patients with mild asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985002-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A double-blind dose-response study of budesonide by inhalation in patients with bronchial asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985002-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985002-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Systemic effects of inhaled fluticasone propionate and budesonide in adult patients with asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985002-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Substitution of beclomethasone aerosol for oral prednisolone in the treatment of chronic asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985002-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Beclomethasone dipropionate aerosol in the treatment of steroid-dependent asthma. A 12-week double-blind study comparing beclomethasone dipropionate and a vehicle aerosol

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985002-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral glucocorticosteroid-sparing effect of budesonide administered by Turbuhaler: a double-blind, placebo-controlled study in adults with moderate-to-severe chronic asthma. Pulmicort Turbuhaler Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985002-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Budesonide delivered by Turbuhaler is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985002-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluticasone propionate results in improved glucocorticoid receptor binding affinity and reduced oral glucocorticoid requirements in severe asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985002-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral steroid-sparing effect of two doses of nebulized fluticasone propionate and placebo in patients with severe chronic asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985002-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluticasone propionate powder: oral corticosteroid-sparing effect and improved lung function and quality of life in patients with severe chronic asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985002-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose-related efficacy of budesonide administered via a dry powder inhaler in the treatment of children with moderate to severe persistent asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985002-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Addition of salmeterol versus doubling the dose of beclomethasone in children with asthma. The Dutch Asthma Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985002-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A multiple-dosing, placebo-controlled study of budesonide inhalation suspension given once or twice daily for treatment of persistent asthma in young children and infants

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985002-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The Effect of Inhaled Fluticasone Propionate in the Treatment of Young Asthmatic Children

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985002-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical efficacy of low-dose inhaled budesonide once or twice daily in children with mild asthma not previously treated with steroids

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985002-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhaled fluticasone propionate delivered by means of two different multidose powder inhalers is effective and safe in a large pediatric population with persistent asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985002-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-dose inhaled budesonide once or twice daily for 27 months in children with mild asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985002-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-dose budesonide improves exercise-induced bronchospasm in schoolchildren

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985002-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of budesonide inhalation suspension (Pulmicort Respules) in young children with inhaled steroid-dependent, persistent asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985002-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Once-daily budesonide inhalation suspension for the treatment of persistent asthma in infants and young children

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985002-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Bayesian approaches to random-effects meta-analysis: a comparative study.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985002-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative efficacy and safety of twice daily fluticasone propionate powder versus placebo in the treatment of moderate asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985002-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma. The Fluticasone Propionate Asthma Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985002-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Effectiveness of fluticasone propionate in patients with moderate asthma: a dose-ranging study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985002-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluticasone propionate compared with theophylline for mild-to-moderate asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985002-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose-related response to inhaled fluticasone propionate in patients with methacholine-induced bronchial hyperresponsiveness: a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985002-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A dose-ranging study of fluticasone propionate administered once daily via multidose powder inhaler to patients with moderate asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985002-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985002-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A controlled trial of chlorofluorocarbon-free triamcinolone acetonide inhalation aerosol in the treatment of adult patients with persistent asthma. Azmacort HFA Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985002-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Placebo-controlled, comparative study of the efficacy and safety of triamcinolone acetonide inhalation aerosol with the non-CFC propellant HFA-134a in patients with asthma. Azmacort HFA Clinical Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985002-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose-ranging study of the clinical efficacy of twice-daily triamcinolone acetonide inhalation aerosol in moderately severe asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985002-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Administration of budesonide once daily by means of turbuhaler to subjects with stable asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985002-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A double-blind, placebo-controlled dose-response study with budesonide Turbuhaler in Japanese asthma patients. Japanese Pulmicort Turbuhaler study group.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985002-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of differing doses of inhaled budesonide on markers of airway inflammation in patients with mild asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985002-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Mometasone furoate administered once daily is as effective as twice-daily administration for treatment of mild-to-moderate persistent asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985002-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Once-daily mometasone furoate dry powder inhaler in the treatment of patients with persistent asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985002-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Rapid onset of control with budesonide Turbuhaler in patients with mild-to-moderate asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985002-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose-ranging study of a new steroid for asthma: mometasone furoate dry powder inhaler

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985002-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A 12-week dose-ranging study of fluticasone propionate powder in the treatment of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985002-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellant.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985002-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Minimum dose requirements of steroid-dependent asthmatic patients for aerosol beclomethasone and oral prednisone

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985002-0

7 January 2021

based on heuristic

inferred from DOI database lookup

An economic evaluation of asthma in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985002-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluticasone propionate reduces oral prednisone use while it improves asthma control and quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985002-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0149-2918(02)85002-0

1 reference

Europe PubMed Central

27 November 2017

1 reference

Europe PubMed Central

27 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43880002&oldid=2140914150"